Chengdu Kangnuoxing Biopharma and Keymed Biosciences patent new CDH17-targeting ADCs
Chengdu Kangnuoxing Biopharma and Keymed Biosciences patent new CDH17-targeting ADCs
Body unavailable. Use the original source.
Chengdu Kangnuoxing Biopharma and Keymed Biosciences patent new CDH17-targeting ADCs
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.